Home > Insider Trading > Filing (0001638599-20-000520)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1420720	Ibio Inc.	IBIO	Pharmaceutical Preparations (2834)	262797813

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1702906	P. James Mullaney	C/O Ibio, Inc. 600 Madison Avenue, Suite 1601 New York NY 10022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-27	11,250	$0.93	0	No	4	M	Direct
Common Stock	Disposition	2020-05-27	11,250	$1.61	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-05-27	11,250	$0.00	11,250	$0.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-02-02	2024-02-20	No	4	M	Direct

Footnotes

Reflects number of securities beneficially owned following all transactions reported on this Form 4.
On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.